Background/objective: Contact dermatitis to topical medicaments is commonly encountered in daily practice of dermatologists. The incidence and ranking of common allergens in topical medicaments may vary depending on local prescription and self-medication behavior. The objective of this study is to investigate the clinical features and common allergens of contact dermatitis to topical medicaments in Taiwan. Methods: From 1978 to 2005, a total of 3717 patients had been patch tested in our Contact Dermatitis Clinic. Any case with suspected contact allergy to topical medicaments receiving patch testing was included in this study. Results: During this period, a total of 608 patients were included and 603 of them completed the patch tests. Of the 603 patch-tested patients, 397 (66%) were positive for at least one antigen, and all patch tests were negative in 206 (34%). Patients with positive patch testing were characterized by younger age and location on the limbs and skin folds, while sex and atopy were not different among the two groups. A total of 1076 positive reactions to identifiable medicaments or main ingredients were recorded in 397 patients with positive patch testing. Among these positive reactions, 701/1076 counts (65%) were read as relevant. Traditional herbal medicaments (50%), antiseptics (21%), vehicle ingredients (9%), antibiotics (8%), corticosteroids (2%), anesthetics (2%), and nonsteroidal anti-inflammatory drugs (1%) were the most common sensitizers in this study, and the common concomitant allergens were fragrance (52%) and metal (20%).
Introduction
Allergic contact dermatitis (ACD) is an inflammatory disease caused by type IV delayed hypersensitivity. 1 In daily clinical practice, dermatologists prescribe various topical medicaments. The use of over-the-counter topical agents is also very popular. Thus, sensitization to topical medicaments occurs from time to time. Previous studies showed that the prevalence of ACD to topical medicaments varied from 14% to 40% of patients in contact clinics. 2, 3 Common allergens in medicaments include local anesthetics, antibiotics, antimicrobials, antivirals, antimycotics, corticosteroids, antihistamines, nonsteroidal anti-inflammatory drugs (NSAIDs), and ingredients of the vehicles. 1e3 However, the incidence and ranking of culprit allergens in topical medicaments may differ across the world due to different local prescribing and selfmedication habits. 4 Factors predisposing to medicament contact dermatitis include the intrinsic sensitizing potential of each drug, higher concentrations, increased penetration, older age, 5 damaged skin barrier, and
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chronic dermatological conditions such as atopic dermatitis. 6, 7 Sites at risk include eyes, 8 vulvae, 9 perianal areas, 10 and leg ulcers. 11 The objective of this study is to investigate the clinical features and common allergens of ACD to topical medicaments in Taiwan.
Methods

Patient history and demographics
The patient data in our study was collected in the Contact Dermatitis Clinic of the National Taiwan University Hospital, a medical center for patch testing in northern Taiwan. The patients consisted of Taiwanese, Hakka, aborigines, and immigrants from Mainland China. 12 From 1978 to 2005, a total of 3717 patients were included. For every patient with suspected ACD seen in this clinic, a questionnaire, as described elsewhere, 13 was completed, which included a detailed history of occupation, affected sites, appearance of the skin lesions, and the possible exposure source. Personal or familial atopy diathesis was considered positive if the patients or their families had atopic dermatitis, allergic rhinitis, or asthma. This study followed the Declaration of Helsinki on medical protocol and ethics. Written informed consent was obtained from all participating adult patients and from parents or legal guardians for minors or incapacitated adults.
Patch testing
Every patient with suspected ACD to topical medicaments received a comprehensive patch test with the European standard series, and the related topical agents were also patch tested. Patch testing followed the protocol recommended by the International Contact Dermatitis Research Group with Finn Chambers (Epitest Ltd Oy, Tuusula, Finland) on Scanpor tapes (Norgesplaster AS, Vennesla, Norway) applied to a lesion-free area on the back. The Scanpor tapes were further affixed with 3M (3M, St Paul, MN, USA) tape. The patches were removed after 2 days; the sites were examined for evidence of reaction on Day 2 (D2) and D4 or on D3 alone. The reading on D3 or D4 was considered positive if the reaction was equal to or stronger than palpable erythema, according to the guidelines of the International Contact Dermatitis Research Group.
12,14
Study design
Patch test data were retrospectively analyzed. Patient history and demographics disclosed in the questionnaire were compared using proper statistics. ACD to topical medicaments was defined as having a positive reaction to at least one of the topical medicaments in the patch test series. The clinical relevance of a positive patch test reaction was defined as previously reported.
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Results
From 1978 to 2005
, 3717 patients were patch tested in our Contact Dermatitis Clinic. Among them, 608 were suspected to be allergic to topical medicaments, of whom 603 completed the patch tests.
Of the 603 patch-tested patients, 397 (66%) were positive for at least one antigen, and all patch tests were negative in 206 (34%). Patient history and demographics are summarized in Table 1 . Patients who reacted to at least one positive antigen on patch testing were defined as "Medicament (þ)," while patients who had negative results were defined as "Medicament (À)." The mean age in the Medicament (þ) group (36.9 ± 15.9 years) was significantly less than that of the Medicament (À) group (40.1 ± 17.5 years). More lesions of the upper limbs, lower limbs, and skin folds were noted in the Medicament (þ) group, while more lesions of the face and trunk were noted in the Medicament (À) group. No difference in sex or atopy diathesis was found among the two groups. A total of 1076 positive reactions to identifiable medicaments or main ingredients were recorded in 397 patients with positive patch testing. The frequency of positive reactions to topical medicaments in each patient were as follows: 138 patients had reactions to only one topical medicament, 90 had ACD to two medicaments, 51 had reactions to three medicaments, and 118 had reactions to more than four medicaments.
Among these positive reactions, 701/1076 counts (65%) were read as relevant. Traditional herbal medicaments (50%), antiseptics (21%), vehicle ingredients (9%), antibiotics (8%), corticosteroids (2%), anesthetics (2%), and NSAIDs (1%) were the most common sensitizers in this study (Figure 1 ). The top five common allergens in traditional herbal medicaments were wind oil, Red Tiger Balm, White Tiger Balm, nutmeg oil, and eucalyptus oil (Table 2) . Thimerosal, ammoniated mercury, nitrofurazone, mercurochrome, and betadine were common allergens in antiseptics, while formaldehyde, amerchol 101, hydrophilic ointment, cetylstearyl alcohol, eucerin, and paraben mix ranked high as common allergens in vehicles (Table 3) . Importantly, neomycin sulfate caused much more positive patch test reactions than fusidic acid, tetracycline, and chloramphenicol (Table 3) . To a total of 53 positive patch test reactions to antimicrobials, neomycin contributed 32 counts (60%). By contrast, fluocinonide (Topsym cream), fluticasone (Cutivate cream), and oxytetracycline and hydrocortisone (Terra-Cortril) were among few allergens found in corticosteroids. Other common allergens in medicaments in Taiwan are also listed in Table 3 . Concomitant allergens were observed in 113 patients. They were classified into fragrance (52%), metal (20%), rubber (8%), cosmetics (7%), and other categories ( Figure 2) . A full list of common concomitant allergens is provided in Table 4 .
Discussion
This hospital-based retrospective study provides demographic and clinical data for ACD to topical medicaments in Taiwan, which also emphasizes the special cultural consideration in Asian patients with ACD to topical medicaments. In our study, 65% of positive patch test reactions reveal clinically relevant ACD. We suggest that clinicians should always be alert to the possibility of ACD to topical medicaments when the treatment response is poor or the treatment course is prolonged.
The effect of age on ACD to topical medicaments is still debatable. Some investigators found that elderly people were more prone to ACD to topical medicaments. 5 Conversely, others argued that people from different age groups are equally likely to have ACD, although the frequency of relevant allergens may differ. 16 Surprisingly, patients with positive patch testing were characterized by younger age in our study. One possibility is that elderly patients with suspected ACD to medicaments are more likely to have irritant contact dermatitis from impaired barrier function rather than true allergy to the medicaments. Another possibility is that the sensitization potential may decrease with age, as has been shown in a previous study that hypersensitivity to nickel steadily decreased with age. 17 Our study demonstrated that patients with lesions on the limbs and skin folds had higher positive patch-testing rates. Stasis ulcers had long been associated with increased hypersensitivity to topical medicaments. Aggravating factors include prolonged course, damaged skin barrier of these chronic ulcers, and usage of occlusive bandages. 3 In a large-scale study in France, allergy to lanolin and neomycin accounts for 21% and 9%, respectively, of patients with stasis ulcers. 11 By comparison, the common sensitizers in patient with stasis ulcers were topical antibiotics (18.2%) and topical traditional Chinese medicaments (15.9%) in Singapore. 18 Topical medications are also among the most common sensitizers in anogenital dermatoses, 9,10 rosacea, and allergic contact conjunctivitis. However, we found that patients with positive patch testing were less likely to have facial lesions. In a retrospective patch-testing study for rosacea patients, only two of 329 patients were positive to neomycin sulfate and one of 100 patients were positive to gentamicin sulfate. 19 Thus, irritant reaction may play a more important role than allergic reaction in rosacea patients. Common allergens in ophthalmic solutions include preservatives, beta blockers, mydriatics, antibiotics, antiviral drugs, antihistaminics, anesthetics, and enzymatic cleaners. 20 In our study, we reviewed seven cases who had ACD to eye drops. Interestingly, six of them showed allergy to antibiotics, such as neomycin or fradiomycin.
As noted in earlier reports, atopic patients are more difficult to be experimentally sensitized to nonprotein allergens and may therefore be less likely to develop ACD. 21 Nevertheless, topical medicaments had been demonstrated as allergens in children with atopic dermatitis. 22 Our study revealed that atopic patients would develop ACD at least as often as nonatopic individuals, which was consistent with previous studies. 23, 24 Traditional herbal medicaments were the most common topical agents that cause ACD in our study. In Asian communities, traditional herbal medicaments are largely sold as over-the-counter products and can be accessed very easily. Usually, these traditional herbal medicaments contain terpenes, salicylates, essential oil extracts, and other crude herbal drugs. 25, 26 Colophony, fragrance, and myrrh are rather frequent allergens in these preparations, and cross-sensitization with these plant extracts contained in traditional herbal medicaments is often. 3 In our previous study, 11.4% of patients who reacted to fragrance mix also had concomitant reactions to topical medicaments. 27 Red Tiger Balm, White Tiger Balm, and White Flower Oil were among the top 10 allergenic traditional herbal medicaments in our study. Previously, similar findings had also been observed in Singapore 28 and Germany. 29 These topical drugs are usually not well labeled. The typical use information provided to the patients discloses only "essential oils" and "aroma agents." 29 Ingredients of the Tiger Balms include camphor, menthol, cajuput oil, clove oil, dementholized mint oil, and paraffin petrolatum. 30 Menthol is a cyclic terpene alcohol, a main component of peppermint oil, and is widely used in medicaments, cosmetics, and confectionaries as a cooling agent. Allergic sensitization to menthol is rare. 31 Yet several reports indicated that menthol sensitization was possible through a compress or transcutaneous patch. 31, 32 These application methods are widely used in Asian communities to enhance the penetration of the ingredients. Compresses containing methyl salicylate or NSAIDs are also commonly used for muscular pain in Asian communities, but they can cause allergic and photoallergic contact dermatitis. 33 Again, Like other salicylates, methyl salicylate may cause fetal salicylate intoxication in children through percutaneous absorption. Localized or generalized urticaria had been reported as well. ACD or irritant contact dermatitis is common, especially under occlusion. 35, 36 As for other NSAIDs, ketoprofen is famous for causing allergy and photoallergy. Noticeably, most cases of ketoprofen sensitization reported to date were from the Mediterranean area, including a large series in France reviewing 136 patients. 37 Nevertheless, in our 20 years of experience, we found only one patient who had photoallergy to ketoprofen, possibly due to the different ethnic/genetic background, skin phototypes, or regional prescription habits. Another NSAID, etofenamate, is a highly lipophilic anthranilic acid derivative. Only a few ACD and photo-ACD cases, and one case of contact urticaria to etofenamate had been reported. 38 Neomycin accounted for 60% of positive reactions to antibiotics, which corresponded to 5.3% of all the patients patch tested in our study. According to the North American Contact Dermatitis Group, the sensitization rates of neomycin stayed relatively constant between 10% and 13% from 1994 to 2006. Thus, it was named the allergen of the year in 2010. 39 A study from United Kingdom showed that the frequency of medicament allergy to neomycin was 10 times more common than that to fusidic acid. 40 The ratio was less striking in our study, reflecting that neomycin sensitization in Taiwan may be underestimated. Documented ACD from acyclovir was rare, and many suggested that the skin reactions were being attributed only to the vehicle components, such as sodium lauryl sulfate and propylene glycol. 41 We found that in one patient patch tests were positive to acyclovir cream, but the patient was not further patch tested with the vehicle tray. Thimerosal, a preservative in vaccines, toxoids, contact lens solutions, and other eye preparations, ranked high among the common antiseptic sensitizers in our study, and so does mercurochrome, another widely used mercurial for surgical disinfection and wound care in the past in Portugal, Spain, and Taiwan. 42 It was very difficult to establish the relevance because mercurials were ubiquitous in vaccines or ophthalmic products, and cross-reactions between mercurials were frequent. By contrast, one study showed that persons allergic to thimerosal were more likely to be allergic to neomycin, bacitracin, and tixocortol pivalate, 43 suggesting a close relationship between thimerosal and topical medicaments. Nitrofurazone, quinolines, and betadine were also identified as allergenic antiseptics in this study. Nitrofurazone and quinolines are well-known sensitizers. Contact allergy to clioquinol occurred more often than that to chlorquinaldol. Nevertheless, crossreaction existed. 44 Providone-iodine could induce skin irritation, necrosis, and rarely contact allergy. 45 We found that topical corticosteroids and local anesthetics accounted for only 2% of positive reactions, respectively, in patients with suspected ACD to medicaments. Topsym cream is the most common allergenic topical corticosteroid in our study. The culprit allergen in Topsym cream might be 1,2,6-hexanetriol present in the cream base. 46 Alternatively, we noticed one in five patients to be allergic to Topsym cream who also had concomitant reaction to formaldehyde. Some believed that formaldehyde and formaldehyde releasers accounted for the majority of reactions in the vehicle and preservative groups in topical corticosteroids. 47 Formaldehyde-releasing preservatives are well-known allergens in topical preparations including medicaments. 48 Formaldehyde sensitization was noted in 3.1% of patients in our study, while propylene glycol, another common allergenic component in vehicles, played no role. The overall prevalence rate of formaldehyde sensitivity was 3.8% in Taiwan, 49 which was slightly higher than the rate (1.3%) published recently by a network in Germany, Switzerland, and Austria. 50 Our government banned formaldehyde use in cosmetics only after 2005, and there is still no regulation on its use in medicaments.
Benzocaine is the most common allergen in topical anesthetic agents, and is often used to treat pruritus ani, hemorrhoids, or pruritus vulvae. Many studies suggested that cross-reactions of benzocaine with other ester derivatives, such as cinchocaine, 51 and amide derivatives, such as lidocaine, 52 occurred frequently. Thus, they concluded that patch testing with benzocaine single agent was inappropriate. However, we did not observe this phenomenon. In terms of topical antihistamines, diphenhydramine, chlorpheniramine, promethazine, chlorpromazine, and doxepin are famous sensitizers. 3 None of the above was noted in this series.
As we mentioned above, concomitant allergies to fragrance and traditional herbal medicaments were widely reported and well demonstrated in our study. Besides fragrance, we discovered that 9.0% of the patients patch tested for suspected ACD to medicaments were also sensitive to nickel and 3.6% to cobalt. The overall prevalence rates of nickel and cobalt sensitivity were, respectively, 17.7% and 7.1% in Taiwan. 13 The above results indicate that there was no obvious cross-sensitization among medicaments and these two common metal allergens. The limitations of our study include the following: it was a retrospective study; patients were selected in a specialized clinic; irritancy reaction may cause false-positive results; low concentration in the whole complex product may cause false-negative results; only selective patients were patch tested with vehicle tray; not all the manufacturers had a goodwill for ingredient labeling; and for some ingredients, correct concentration and vehicle for patch tests were not determined. 
